4.5 Article

Inhalable chitosan nanoparticles as antitubercular drug carriers for an effective treatment of tuberculosis

Journal

ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY
Volume 44, Issue 3, Pages 997-1001

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.3109/21691401.2015.1008508

Keywords

chitosan nanoparticle; in vivo studies; pulmonary drug delivery; tuberculosis

Funding

  1. Department of Biotechnology (DBT), New Delhi, India [BT/01/IYBA/2009]

Ask authors/readers for more resources

The aim of this study was to prepare and characterize spray dried inhalable chitosan nanoparticles (CNPs) for sustained delivery of anti-tubercular drugs, isoniazid (INH) and rifampicin (RIF), to the lungs. CNPs were prepared by ionic gelation technique followed spray drying. Results showed that the CNPs obtained had a smooth spherical shape with an average size of 230 +/- 4.5 nm, with a poly dispersity index of 0.180 +/- 0.021. Both drugs, were detected in various organs (lungs, liver, spleen and kidney) until 24 h post nebulization. The chemotherapeutic efficacy of a single dose of drug-loaded CNPs suggested that they are more effective against the mycobacterium than free drugs.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available